The lumbar intervertebral body fusion device is indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1. It can be implanted via posterior, transforaminal or lateral approach.
The device is a part of Interventional Spine’s family of Opticage Expandable Interbody Fusion Devices cleared for TLIF earlier this year.
More articles on devices:
Investor notes: 6 spine device company updates
Yale student scoliosis brace tracking device startup gets $100k
Vivex Biomedical acquires University of Miami Tissue Bank assets
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
